Clinical trial
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
NCT00011778 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00011778 |
|---|---|
| Title | PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck |
| Official title | A Phase I Study of Concomitant Therapy With Proteasome Inhibitor PS-341 and Radiation in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma |
| Intervention type | Drug, Radiation |
| Interventions | bortezomib, radiation therapy |
| Enrollment | 25 |
| Start date | Feb 22, 2001 |
| Primary completion | Aug 26, 2010 |
| Completion | Feb 8, 2013 |
| First posted | Mar 1, 2001 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: